In a recent Seznam Zprávy article, journalist Filip Horáček traces Michal Zahradníček’s journey from running a successful IT distribution company whose clients included Petr Kellner to co-founding LIFE BioCEEd. After selling his former firm, Michal dedicated himself to advancing regenerative medicine through Primecell, and today he leverages that expertise to close Europe’s tech-transfer gap with LIFE BioCEEd. The company has brought together CZK 500 million in investor commitments and partners with leading universities and research institutes across Central and Eastern Europe. Its mission is to scout the most promising medical inventions, guide them from patent stage through development, and bring them to global markets.
Read the full article here: